Concepedia

Gerald W. Shipps

GW

36

Publications

1.9K

Citations

23

H-Index

1993

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Massachusetts Institute of Technology

Scripps Research Institute

Angiogenesis Foundation

Gerald W. Shipps is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1993–2018

36

Publications

36

Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors

Erick J. Morris, Sharda Jha, Clifford R. Restaino et al. · Cancer Discovery · 2013 · 673 citations · Full text

, , +20

Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors

Stergios J. Moschos, Ryan J. Sullivan, Wen-Jen Hwu et al. · JCI Insight · 2018 · 145 citations · Full text

An affinity selection–mass spectrometry method for the identification of small molecule ligands from self-encoded combinatorial libraries

D. Allen Annis, John Athanasopoulos, Patrick J. Curran et al. · International Journal of Mass Spectrometry · 2004 · 98 citations

, , +9

The activated core approach to combinatorial chemistry: A selection of new core molecules

Kent E. Pryor, Gerald W. Shipps, David Skyler et al. · Tetrahedron · 1998 · 83 citations

, , +8

Discovery and optimization of antibacterial AccC inhibitors

Cliff C. Cheng, Gerald W. Shipps, Zhiwei Yang et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 57 citations

, , +8

Rows per page

1–5 of 36